Kuvatris Therapeutics, Inc.
PXMDDelisted Aug 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811623
Kuvatris Therapeutics, Inc. was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Mar 14, 2024; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Kuvatris Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 10 | 8 | −2 |
| Shares | 161.1K | 210.9K | +49.8K (+30.9%) |
| Value | $307.6K | $165.3K | −$142.2K (−46.2%) |
New holders (2)
Institutions that held Kuvatris Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 68,991 | $54.2K | 0.00% |
| HRT Financial LP | 25,982 | $20.0K | 0.00% |
Sold out (4)
Institutions that held Kuvatris Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| UBS Group AG | 17,735 | $33.9K |
| Susquehanna International Group, LLP | 13,678 | $26.1K |
| Virtu Financial LLC | 12,827 | $24.0K |
| Advisor Group Holdings, Inc. | 1,000 | $1.91K |